BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32446873)

  • 41. Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.
    Subirà M; Martino R; Gómez L; Martí JM; Estany C; Sierra J
    Eur J Haematol; 2004 May; 72(5):342-7. PubMed ID: 15059069
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Self-assembling cashew gum-graft-polylactide copolymer nanoparticles as a potential amphotericin B delivery matrix.
    Richter AR; Carneiro MJ; de Sousa NA; Pinto VPT; Freire RS; de Sousa JS; Mendes JFS; Fontenelle ROS; Feitosa JPA; Paula HCB; Goycoolea FM; de Paula RCM
    Int J Biol Macromol; 2020 Jun; 152():492-502. PubMed ID: 32097738
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long chain fatty acid conjugation remarkably decreases the aggregation induced toxicity of Amphotericin B.
    Thanki K; Prajapati R; Sangamwar AT; Jain S
    Int J Pharm; 2018 Jun; 544(1):1-13. PubMed ID: 29635057
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of albumin dialysis on pharmacokinetics of amphotericin B colloidal dispersion and amphotericin B lipid complex.
    Weiler S; Vogelsinger H; Joannidis M; Dunzendorfer S; Bellmann R
    Artif Organs; 2011 Jun; 35(6):667-71. PubMed ID: 21668831
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Super aggregated form of Amphotericin B: a novel way to increase its therapeutic index.
    Zia Q; Azhar A; Kamal MA; Aliev G; Owais M; Ashraf GM
    Curr Pharm Des; 2016; 22(7):792-803. PubMed ID: 26648472
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and
    Rossi SA; de Oliveira HC; Agreda-Mellon D; Lucio J; Mendes-Giannini MJS; García-Cambero JP; Zaragoza O
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988099
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amphotericin B-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): effect of drug loading and biopharmaceutical characterizations.
    Jansook P; Pichayakorn W; Ritthidej GC
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1693-1700. PubMed ID: 29936874
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Self assembled ionically sodium alginate cross-linked amphotericin B encapsulated glycol chitosan stearate nanoparticles: applicability in better chemotherapy and non-toxic delivery in visceral leishmaniasis.
    Gupta PK; Jaiswal AK; Asthana S; Verma A; Kumar V; Shukla P; Dwivedi P; Dube A; Mishra PR
    Pharm Res; 2015 May; 32(5):1727-40. PubMed ID: 25425053
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synergistic Antifungal Effect of Amphotericin B-Loaded Poly(Lactic-Co-Glycolic Acid) Nanoparticles and Ultrasound against Candida albicans Biofilms.
    Yang M; Du K; Hou Y; Xie S; Dong Y; Li D; Du Y
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670414
    [No Abstract]   [Full Text] [Related]  

  • 50. Efficacy and toxicity evaluation of new amphotericin B micelle systems for brain fungal infections.
    Moreno-Rodríguez AC; Torrado-Durán S; Molero G; García-Rodríguez JJ; Torrado-Santiago S
    Int J Pharm; 2015 Oct; 494(1):17-22. PubMed ID: 26256151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis.
    Lewis RE; Liao G; Hou J; Chamilos G; Prince RA; Kontoyiannis DP
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1253-8. PubMed ID: 17261624
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potassium depletion potentiates amphotericin-B-induced toxicity to renal tubules.
    Bernardo JF; Murakami S; Branch RA; Sabra R
    Nephron; 1995; 70(2):235-41. PubMed ID: 7566310
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B.
    Alvarez C; Shin DH; Kwon GS
    Pharm Res; 2016 Sep; 33(9):2098-106. PubMed ID: 27198671
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and anti-Candida evaluation of the vaginal delivery system of amphotericin B nanosuspension-loaded thermogel.
    Ci T; Yuan L; Bao X; Hou Y; Wu H; Sun H; Cao D; Ke X
    J Drug Target; 2018 Nov; 26(9):829-839. PubMed ID: 29378463
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate.
    Bekersky I; Fielding RM; Dressler DE; Lee JW; Buell DN; Walsh TJ
    Antimicrob Agents Chemother; 2002 Mar; 46(3):834-40. PubMed ID: 11850269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biomolecular interactions of amphotericin B nanomicelles with serum albumins: A combined biophysical and molecular docking approach.
    Temboot P; Usman F; Ul-Haq Z; Khalil R; Srichana T
    Spectrochim Acta A Mol Biomol Spectrosc; 2018 Dec; 205():442-456. PubMed ID: 30055454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A brain-vectored angiopep-2 based polymeric micelles for the treatment of intracranial fungal infection.
    Shao K; Wu J; Chen Z; Huang S; Li J; Ye L; Lou J; Zhu L; Jiang C
    Biomaterials; 2012 Oct; 33(28):6898-907. PubMed ID: 22789719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conventional Amphotericin B Associated Nephrotoxicity in Patients With Hematologic Malignancies.
    Gursoy V; Ozkalemkas F; Ozkocaman V; Serenli Yegen Z; Ethem Pinar I; Ener B; Akalın H; Kazak E; Ali R; Ersoy A
    Cureus; 2021 Jul; 13(7):e16445. PubMed ID: 34422476
    [TBL] [Abstract][Full Text] [Related]  

  • 59. AmBisome: relationship between the pharmacokinetic characteristics acquired by liposomal formulation and safety/efficacy.
    Takemoto K; Kanazawa K
    J Liposome Res; 2017 Sep; 27(3):186-194. PubMed ID: 27328721
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice.
    Espuelas MS; Legrand P; Campanero MA; Appel M; Chéron M; Gamazo C; Barratt G; Irache JM
    J Antimicrob Chemother; 2003 Sep; 52(3):419-27. PubMed ID: 12888593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.